Be Ready Pack Learn more about how Myriad myrisk is revolutionizing hereditary cancer testing.

Similar documents
A Patient s Guide to Hereditary Cancer. Is Hereditary Cancer Testing Right for You?

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

Hereditary Cancer Products

Myriad Financial Assistance Program (MFAP)

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP)

Does Cancer Run in Your Family?

The benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide

GYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer

A guide to genetic testing for hereditary cancers

Understanding Your Positive Result. A guide to understanding your risk and taking action

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Hereditary Colorectal Cancer

Learn your genetic risk for the most common hereditary cancers.

GYNplus. genetic testing for hereditary ovarian and/or uterine cancer

Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)

The Next Generation of Hereditary Cancer Testing

Sporadic Cancer - Cancer which occurs by chance. People with sporadic cancer typically do not have relatives with the same type of cancer.

Adenomatous Polyposis Syndromes (FAP/AFAP and MAP)

patient guide CancerNext genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention

A Patient s Guide to. Hereditary Ovarian Cancer: Is Hereditary Cancer Testing Right for You?

Objectives. Genetics in Cancer Treatment and Prevention. Genes

CentoCancer STRIVE FOR THE MOST COMPLETE INFORMATION

Assessment and Management of Genetic Predisposition to Breast Cancer. Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18

OvaNext. patient guide. genetic testing for hereditary breast, ovarian, and uterine cancer

Genetic testing for hereditary cancer

What a history of cancer may mean for you and your family and the steps you can take to reduce the risk

patient guide CancerNext-Expanded genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention

BRCAplus. genetic testing for hereditary breast cancer

patient guide BreastNext genetic testing for hereditary breast cancer Because knowing your risk can mean early detection and prevention

Why Test for Hereditary Cancer in Preventive Care?

GeneticsNow TM. A Guide to Testing Hereditary Conditions in Women & Men. Patient & Physician Information

Genetic Risk Assessment for Cancer

Cancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor

Genetic Testing: who, what, why?

Are you at risk of Hereditary Cancer? Your Guide to the Answers

Genetic Testing for BRCA1 and BRCA2 Genes

A Patient s Guide to risk assessment. Hereditary Colorectal Cancer

Expert Interview: Inherited Susceptibility to Cancer with Dr. Nicoleta Voian

Genetic Risk Assessment for Cancer

Genetic Determinants, Risk Assessment and Management

Understanding Your Genetic Test Result. Positive for Two Copies of an MYH Mutation

Genetic testing and pancreatic disease

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017

Clinical Cancer Genetics

GHUK BowelGene_2017.qxp_Layout 1 22/02/ :22 Page 3 BowelGene

patient guide ProstateNext genetic testing for hereditary prostate cancer Because knowing your risk can mean early detection and prevention

Primary Care Approach to Genetic Cancer Syndromes

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

patient guide PancNext genetic testing for hereditary pancreatic c a ncer Because knowing your risk can mean early detection and prevention

Genetic Testing for Familial Gastrointestinal Cancer Syndromes. C. Richard Boland, MD La Jolla, CA January 21, 2017

Prior Authorization. Additional Information:

Genetic Testing for BRCA1 and BRCA2 Genes

A pathogenic mutation was identified in the BRCA1 gene.

Genetic Testing for Lynch Syndrome

Carol Christianson, MS, CGC Genetic Counselor West Michigan Cancer Center

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Yes when meets criteria below. Dean Health Plan covers when Medicare also covers the benefit.

BowelGene. How do I know if I am at risk? Families with hereditary bowel cancer generally show one or more of the following clues:

WELCOME. Taking Care of Your Health. April 30, 8 am to noon

Use of panel tests in place of single gene tests in the cancer genetics clinic

Germline Multigene Panel Testing in Oncology: Genetic Counseling Perspective

Hereditary Cancer Update: What do GPOs need to know?

The Role of genetic Testing for Inherited Prostate Cancer Risk

Germline Testing for Hereditary Cancer with Multigene Panel

So, now, that we have reviewed some basics of cancer genetics I will provide an overview of some common syndromes.

Genetic Testing Today: What Genes Can Tell Us. Living Beyond Breast Cancer Conference Kara N. Maxwell, MD, PhD University of Pennsylvania

Understanding Your Genetic Test Result. Positive for a Deleterious Mutation or Suspected Deleterious

Family Assessment. Objectives. Comprehensive Family History Important Inexpensive Underutilized genetic tool

Does Cancer Run in Your Family?

Proactive Patient Paves the Way for Genetic Testing of Eight Family Members

BRCAnowTM It s Your Decision

Management of BRCA Positive Breast Cancer. Archana Ganaraj, MD February 17, 2018 UPDATE ON WOMEN S HEALTH

Information for You and Your Family

MEDICAL POLICY Genetic Testing for Breast and Ovarian Cancers

Genetics & Precision Medicine Cancer Care

10/21/ New Release, Quest Diagnostics Nichols Institute, Valencia

Hereditary Cancer Risk Assessment for Gynecological Cancers. FarrNezhatMD.com

patient guide MelanomaNext genetic testing for hereditary melanoma Because knowing your risk can mean early detection and prevention

Versus. Cancer genomics Competitive Analysis

Incorporating Hereditary Cancer Risk Assessment into Your Practice

Hereditary Aspects of Pancreatic Cancer

GENETIC TESTING FOR HEREDITARY CANCER

GeneHealth BreastGene_New qxp_Layout 1 21/02/ :42 Page 3 BreastGene GeneHealth UK

11/29/2017. Genetics and Cancer ERICA L SILVER, MS, LCGC GENETIC COUNSELOR. Genetics 101. Transcription vs Translation

ProstateGene What is hereditary prostate cancer? What are genes?

GEN ETICS AN D GEN OM ICS IN CANCER PREVENTION AN D TREATM EN T. Robert Nathan Slotnick MD PhD Director, Medical Genetics and Genomics

DO YOU HAVE A FAMILY HISTORY OF ONE OF THESE CANCERS? BREAST, OVARIAN, COLORECTAL, ENDOMETRIAL, PANCREAS, PROSTATE, STOMACH OR SKIN CANCERS?

Genetic testing for hereditary cancer. An overview for healthcare providers

HEREDITARY CANCER SYNDROMES: IDENTIFYING THOSE AT RISK

Hereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG

Corporate Medical Policy

Hereditary Cancer Update Strengthening Linkages Workshop April 22, 2017

ProstateGene GeneHealth UK

The Value of Panel Testing in Inherited Breast Cancer Risk Assessment. Rodney J. Scott Division of Molecular Medicine

Hereditary Non Polyposis Colorectal Cancer(HNPCC) From clinic to genetics

Transcription:

Be Ready Pack Learn more about how Myriad myrisk is revolutionizing hereditary cancer testing.

Hereditary cancer and you Approximately 5% to 10% of all cancers develop because a person inherited a genetic mutation in a way that encourages the disease to grow. Individuals with these genetic mutations are far more likely to develop certain cancers, often at a much earlier age than the general population. Understanding your cancer risk Medical management of people with a higher cancer risk (ie, hereditary risk) can be very different from that for people with a lower cancer risk (ie, general population risk). You and your healthcare provider can determine your cancer risk and course of management by understanding your family history and pursuing hereditary cancer testing when appropriate. GENERAL POPULATION Personalized cancer risk-reduction plan Patient 1 Regular Screening(s) FAMILY-BASED CANCER RISK HEREDITARY Patient 2 Improved screening(s) Preventive medication(s) Risk-reducing procedure(s) Considerations for family Other management changes Red flags to further assess hereditary cancer After careful review, your healthcare provider determined that Myriad myrisk TM Hereditary Cancer was the right genetic test for you because your personal and/or family history matched one or more of the risk factors below for increased hereditary cancer risk. An individual with a personal and/or family history of any ONE of the following: MULTIPLE A combination of cancers on the same side of the family YOUNG Any 1 of the following cancers at age 50 or younger RARE Any 1 of these rare presentations at any age 2 or more: breast / ovarian / prostate / pancreatic cancer 2 or more: colorectal / endometrial / ovarian / gastric / pancreatic / other cancers (i.e., ureter/renal pelvis, biliary tract, small bowel, brain, sebaceous adenomas) 2 or more: melanoma / pancreatic cancer Breast cancer Colorectal cancer Endometrial cancer Ovarian cancer Breast: male breast cancer or triple-negative breast cancer Colorectal cancer with abnormal MSI/IHC, MSI- associated histology * Endometrial cancer with abnormal MSI/IHC 10 or more gastrointestinal polyps * Presence of tumor-infiltrating lymphocytes, Crohn s-like lymphocytic reaction, mucinous/signet ring differentiation, or medullary growth pattern. Adenomatous type. Assessment criteria are based on medical society guidelines. For these individual medical society guidelines, go to www.myriadpro.com/guidelines. Family members include first-, second-, and third-degree blood relatives on both your mother s and father s sides. People with certain ancestries may have greater risk for hereditary cancer syndromes (e.g., Ashkenazi Jewish ancestry). 2 3

What is Myriad myrisk? Myriad myrisk is the only hereditary cancer test that combines your genetic information with the personal and family history you give your healthcare provider to generate guideline-based management options to help you lower cancer risks. What does Myriad myrisk do for me? The test result provides critical information for your healthcare provider to make optimal medical decisions and take action in building a personalized cancer risk-reduction plan. What does Myriad myrisk test for? Myriad myrisk looks at multiple genes that impact inherited risks for eight important cancers. Testing multiple genes helps avoid missing mutations. Why Myriad myrisk? About Myriad myrisk Myriad myrisk analyzes 25 genes associated with cancer risks ENDOMETRIAL PROSTATE MELANOMA BRCA1, BRCA2 BREAST PANCREATIC Examples TP53 OVARIAN GASTRIC COLORECTAL BMPR1A, SMAD4 Gene panel includes: BRCA1, BRCA2, MLH1, MSH2, MSH6, PMS2, EPCAM, APC, MUTYH, CDKN2A, CDK4, TP53, PTEN, STK11, CDH1, BMPR1A, SMAD4, PALB2, CHEK2, ATM, NBN, BARD1, BRIP1, RAD51C, RAD51D Myriad myrisk incorporates your family history and genetic results to help optimize your medical management. Myriad myrisk is the gold standard in accuracy and offers fast turnaround time for panel testing. Myriad myrisk report overview Myriad myrisk reports can be positive or negative for genetic mutations known to increase cancer risk. The management plan that you and your healthcare provider follow may need to change based on the findings of cancer risk. If your result is positive You carry a genetic mutation that increases your cancer risk. There are many ways to manage your cancer risk. The Myriad myrisk report is a helpful tool for you to understand some of your options. The report your healthcare provider receives will include information about the genetic mutation and your personal and/or family cancer history. Both may contribute to increased cancer risk. Management recommendations for specific cancer risks are generated on the basis of wellestablished and respected medical guidelines. These recommendations may help you and your healthcare provider discuss and determine the right course of management for you and your family. Talking with family members about your test result is very important so they can take steps to determine their own risk. If your result is negative You do not carry a known genetic mutation that increases cancer risk. However, it is not uncommon for cancer(s) to run in the family even when there is no identified genetic cause. If this is the case for you, you might still have a higher risk than the general population because of the unexplained cancer family history. As a result, your healthcare provider may want to personalize a management plan on the basis of your personal and/or family history. It is important that you continue to update your healthcare provider with a complete and accurate cancer family history. This helps to manage your cancer risks appropriately. 4 5

Other questions you might be asking Who is Myriad? With over 20 years of experience and more than one million people tested, Myriad is the established leader in the field of hereditary genetic testing. Myriad s genetic tests are known for quality and accuracy. The extensive knowledge base, a highly specialized professional staff, and the commitment to support healthcare providers make Myriad the unquestioned leader in genetic testing for hereditary cancer. What is Myriad s lifetime commitment? Myriad performs ongoing investigations and research on all findings. Your healthcare provider will be contacted if new genetic information affects your medical management. Patients who were previously tested by Myriad are eligible for affordable Myriad myrisk TM Update Testing to update their personal cancer risk-reduction plan. Can my health insurance coverage be impacted by the results? Federal laws (HIPAA and GINA) and laws in most states prohibit discrimination regarding employment eligibility, health benefits, or health insurance premiums solely on the basis of genetic information. Additionally, it is Myriad s policy that test results are disclosed only to the ordering healthcare professional or designee unless the patient chooses otherwise. Will my health insurance pay for my testing? Most insurance carriers cover genetic testing services for hereditary cancer. In fact, most appropriate patients pay $0. Myriad helps you receive the appropriate coverage from your plan. Please read the important information about the Myriad Promise TM on the next page. Where can I find patient support? Visit www.mysupport360.com to learn more. mysupport360 is a website where patients and their families can learn about other patients experiences and gather comprehensive information about hereditary cancer syndromes what they are, what the risks are, and what can be done about them. Your experience can be completely personalized so that you receive reminders about appointments and options for management. Financial support and flexibility We partner to ensure your satisfaction At Myriad, we believe every patient should have access to the highest quality genetic testing because we know how useful it is in helping healthcare providers deliver the best medical care. Our promise When one of our tests is ordered for you, we will work with your insurance provider to help you get the appropriate coverage allowed by your plan We also offer testing at no charge to uninsured and under insured patients who meet specific financial and medical criteria. Visit ms360.myriad.com/genetictesting/insurance to learn more Most appropriate patients pay $0 If you have concerns when you receive an invoice from Myriad, you can call the telephone number on the invoice. We guarantee that we will work with you to reach a solution Our commitment We are committed to making sure that test results are accurate, timely, and financially accessible to everyone. 6 7

A lifetime of patient support mysupport360 is a community that Helps guide patients and their family members through the genetic testing process Provides valuable information along the way and serves as an avenue to hear from others who are facing the same decisions Whether you are undertaking the hereditary cancer testing journey for yourself, a loved one, or a friend, the mysupport360 mission as an addition to your medical support team is to put you in control, enabling you to own your healthcare. mysupport360 will help keep you informed, proactive, and confidently prepared throughout the process. Visit www.mysupport360.com to learn more Myriad Genetic Laboratories, Inc. 320 Wakara Way Salt Lake City, UT 84108 1-800-469-7423 Myriad, the Myriad logo, Myriad myrisk Hereditary Cancer, the Myriad myrisk Hereditary Cancer logo, Myriad Promise, the Myriad Promise logo, mysupport360, and the mysupport360 logo are either trademarks or registered trademarks of Myriad Genetics Inc. in the United States and other jurisdictions. 2014, Myriad Genetic Laboratories, Inc. MRHCPTOV/06-14